Search for: "In Re: Plavix Marketing, Sales Practices and Products Liability Litigation" Results 1 - 5 of 5
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
27 Oct 2011, 4:24 am by Max Kennerly, Esq.
That didn’t matter much to Ortho-McNeil Pharmaceutical, a Johnson & Johnson subsidiary, which: [P]romoted the sale of Topamax for off-label psychiatric uses through a practice known as the “Doctor-for-a-Day” program. [read post]
2 May 2008, 7:00 am
: (Dilanchian), The three dysfunctions of a complex IP legal team: (IP Law360), IP litigation and WIPO: (Ezine @rticles), Time to nominate IP Hall of Fame inductees: (IAM), Product packaging and patent protection: (IP Law360), Understanding the value of IPRs in the context of fashion and visual arts: (Ezine @articles) Global - Trade Marks / Domain Names / Brands How logos, shapes and colours are remembered: (Class 46), Now obsolete .su (Soviet Union)… [read post]
23 Aug 2008, 1:23 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com]   Highlights this week included: DRM for streaming music dies a quiet death: (Electronic Frontier Foundation), (Techdirt) CAFC decides Apotex and Impax infringed AstraZeneca’s Prilosec patents: (Law360), (Patent Prospector), (Patent Docs), (GenericsWeb), CAFC upholds lower court’s decision finding USPTO was within its rights to subject a Cooper patent to… [read post]
2 Aug 2008, 12:54 am
: (Holman’s Biotech IP Blog), Daiichi’s open offer for 20% in Ranbaxy awaits Sebi nod: (GenericsWeb), Australia/India: Strides shows thumbs up for Indian generic industry acquiring controlling interest in Ascent: (Spicy IP), Europe: Significant date ahead for EU Paediatric Regulation: (SPC Blog), India: Grave diggers, ‘immoral’ patent and the National Biotech Regulatory Authority: (Spicy IP), UK: Monster trade mark infringement case: court reveals its thinking… [read post]